five specialized inter and intrarun replicates have been assessed for concordance based upon methylation variant pathogenicity (MVP) score (inside of 0.05) and clustering analysis. The medical testing cohort (desk S2) includes peripheral blood DNA samples from 207 topics, referred by doctors depending on unique scientific discretion, who definitel